MedPharm has appointed Bill Humphries as its new CEO, marking a significant step in the company's strategic growth. The move ...

The adoption of telemedicine and remote monitoring technologies in ophthalmology to accelerate the market growth, says Fact.MR in its new market rese ...

AbbVie launched a revamped version of its Allē loyalty program, which ultimately was not adopted by providers. The marketing ...

Good morning, and thank you for standing by. Welcome to the AbbVie fourth-quarter 2024 earnings conference call. (Operator Instructions) Today's call is also being recorded. If you have any objections ...

AbbVie's acquisition of Allergan significantly increased the firm's debt level. We expect the firm's net debt position to peak at close to $70 billion in 2020 but given the strong cash flows of AbbVie ...

A whistleblower lost his bid to reinstate a False Claims Act suit alleging that Allergan Inc. and Adamas Pharmaceuticals Inc. fraudulently obtained patents on two drugs to combat Alzheimer’s disease.

Mr. Finney brings 35 years of leadership, operations and corporate development experienceSOUTH SAN FRANCISCO, Calif., Jan. 28, 2025 (GLOBE ...

A Manhattan aesthetician was arrested and charged with wire fraud and smuggling after injecting patients at his medical spa ...

Joining Allergan Aesthetics was also serendipity as I applied for a different role than I currently hold. Although I was not the right person at the right time for that role, the recruiting team must ...

A whistleblower accusing Allergan Inc. of engaging in a kickback scheme to increase purchases of “Lap-Band’ obesity devices can advance a portion of his suit toward trial, a Maryland federal judge ...

You are responsible for reading, understanding, and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy ...